LEUCID BIO LTD

Active Cambridge

Research and experimental development on biotechnology

20 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
L

LEUCID BIO LTD

Research and experimental development on biotechnology

Founded 27 Nov 2014 Active Cambridge, England 20 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 27 Dec 2025 Next due 31 Mar 2027 11 months remaining
Confirmation Submitted 19 Dec 2025 Next due 11 Dec 2026 7 months remaining
Net assets £2M £3M 2025 year on year
Total assets £3M £435K 2025 year on year
Total Liabilities £1M £3M 2025 year on year
Charges 2
1 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

Building 1000 Beach Drive Waterbeach Cambridge CB25 9PD England

Website

www.example.com

Full company profile for LEUCID BIO LTD (09331486), an active life sciences and medical technology company based in Cambridge, England. Incorporated 27 Nov 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2015–2025)

Cash in Bank

£2.20M

Increased by £541.11k (+33%)

Net Assets

£2.25M

Increased by £2.99M (+405%)

Total Liabilities

£1.16M

Decreased by £2.56M (-69%)

Turnover

N/A

Employees

20

Decreased by 2 (-9%)

Debt Ratio

34%

Decreased by 91 (-73%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 1Oct 2021Series A
Investor 2Oct 2021Series A
Investor 3Oct 2021Series A

Share Capital

Share Capital

Share allotments and capital structure

15 Allotments 11,951,100 Shares £19.18m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
26 Feb 20259,375£9.38£9.38
26 Feb 202510,938£10.94£10.94
13 Feb 2025166,666£250k£1.5
13 Feb 202571,429£71.429£0.001
13 Feb 20253,136,857£3.29m£1.05

Officers

Officers

2 active 1 resigned
Status
Filippo Joseph PettiDirectorAmericanUnited States5017 Jul 2023Active
Peter Michael FinanDirectorBritishEngland5826 Jun 2017Active

Shareholders

Shareholders (19)

Epidarex Capital Iii Uk, Lp
18.9%
3,613,829
2invest Ag
17.7%
3,374,952

Persons with Significant Control

Persons with Significant Control (0)

0 Active 4 Ceased

King's College London

Ceased 24 Jun 2021

Ceased

Epidarex Capital Ii Lp

Ceased 4 Jul 2017

Ceased

Anthony Ian Walker

Ceased 3 Jul 2017

Ceased

Sofinnova Partners Sas

Ceased 15 Dec 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Dec 2025AccountsAnnual accounts made up to 2025-06-30
19 Dec 2025Confirmation StatementConfirmation statement made on 2025-11-27 with updates
7 Apr 2025AccountsAnnual accounts made up to 2024-06-30
24 Mar 2025OfficersAppointment of Mr Heikki Lanckriet as director on 2025-02-13
6 Mar 2025CapitalAllotment of shares (GBP 19,087.975) on 2025-02-26
27 Dec 2025 Accounts

Annual accounts made up to 2025-06-30

19 Dec 2025 Confirmation Statement

Confirmation statement made on 2025-11-27 with updates

7 Apr 2025 Accounts

Annual accounts made up to 2024-06-30

24 Mar 2025 Officers

Appointment of Mr Heikki Lanckriet as director on 2025-02-13

6 Mar 2025 Capital

Allotment of shares (GBP 19,087.975) on 2025-02-26

Recent Activity

Latest Activity

Annual accounts made up to 2025-06-30

4 months ago on 27 Dec 2025

Confirmation statement made on 2025-11-27 with updates

4 months ago on 19 Dec 2025

Annual accounts made up to 2024-06-30

1 years ago on 7 Apr 2025

Appointment of Mr Heikki Lanckriet as director on 2025-02-13

1 years ago on 24 Mar 2025

Allotment of shares (GBP 19,087.975) on 2025-02-26

1 years ago on 6 Mar 2025